|
|||||
|
 | |
| |
| |
| |
| |
| |
|
Gene: NPIPB12 |
Gene summary for NPIPB12 |
 Gene summary. |
| Gene information | Species | Human | Gene symbol | NPIPB12 | Gene ID | 440353 |
| Gene name | nuclear pore complex interacting protein family member B12 | |
| Gene Alias | NPIPB12 | |
| Cytomap | 16p11.2 | |
| Gene Type | protein-coding | GO ID | GO:0005575 | UniProtAcc | NA |
Top |
Malignant transformation analysis |
| Identification of the aberrant gene expression in precancerous and cancerous lesions by comparing the gene expression of stem-like cells in diseased tissues with normal stem cells |
| Malignant transformation involving gene list. |
| Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
| 440353 | NPIPB12 | HTA11_4255_2000001011 | Human | Colorectum | SER | 2.45e-04 | 3.45e-01 | 0.0446 |
| 440353 | NPIPB12 | HTA11_8622_2000001021 | Human | Colorectum | SER | 2.12e-02 | 1.88e-01 | 0.0528 |
| 440353 | NPIPB12 | HTA11_7663_2000001011 | Human | Colorectum | SER | 8.62e-08 | 4.36e-01 | 0.0131 |
| 440353 | NPIPB12 | HTA11_10623_2000001011 | Human | Colorectum | AD | 9.48e-10 | 4.52e-01 | -0.0177 |
| 440353 | NPIPB12 | HTA11_10711_2000001011 | Human | Colorectum | AD | 8.31e-28 | 6.14e-01 | 0.0338 |
| 440353 | NPIPB12 | HTA11_7696_3000711011 | Human | Colorectum | AD | 3.70e-09 | 2.68e-01 | 0.0674 |
| 440353 | NPIPB12 | HTA11_6818_2000001011 | Human | Colorectum | AD | 2.40e-17 | 7.11e-01 | 0.0112 |
| 440353 | NPIPB12 | HTA11_11156_2000001011 | Human | Colorectum | AD | 9.72e-05 | 5.17e-01 | 0.0397 |
| 440353 | NPIPB12 | HTA11_6818_2000001021 | Human | Colorectum | AD | 6.29e-07 | 3.16e-01 | 0.0588 |
| Page: 1 2 |
| Transcriptomic changes along malignancy continuum. |
| Tissue | Expression Dynamics | Abbreviation |
| Colorectum (GSE201348) |  | FAP: Familial adenomatous polyposis |
| CRC: Colorectal cancer | ||
| Colorectum (HTA11) |  | AD: Adenomas |
| SER: Sessile serrated lesions | ||
| MSI-H: Microsatellite-high colorectal cancer | ||
| MSS: Microsatellite stable colorectal cancer |
| ∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
| Find out the enriched GO biological processes and KEGG pathways involved in transition from healthy to precancer to cancer |
| Figure of enriched GO biological processes. |
| Tissue | Disease Stage | Enriched GO biological Processes |
| Colorectum | AD |  |
| Colorectum | SER |  |
| Colorectum | MSS |  |
| Colorectum | MSI-H |  |
| Colorectum | FAP |  |
| ∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
| Page: 1 2 3 4 5 6 7 8 9 |
| Enriched GO biological processes. |
| GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
| Page: 1 |
| Enriched KEGG pathways. |
| Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
| Page: 1 |
Top |
Cell-cell communication analysis |
| Identification of potential cell-cell interactions between two cell types and their ligand-receptor pairs for different disease states |
| Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
| Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
| Find out the significant the regulons (TFs) and the target genes of each regulon across cell types for different disease states |
| TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
| ∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
| Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
| Annotation of somatic variants for genes involved in malignant transformation |
| Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
| NPIPB12 | SNV | Missense_Mutation | novel | c.792N>T | p.Lys264Asn | p.K264N | protein_coding | deleterious_low_confidence(0) | probably_damaging(0.99) | TCGA-A5-A0G2-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD |
| Page: 1 |
Top |
Related drugs of malignant transformation related genes |
| Identification of chemicals and drugs interact with genes involved in malignant transfromation |
| (DGIdb 4.0) |
| Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
| Page: 1 |
Copyright 2023-Present -The University of Texas Health Science Center at Houston |